CU20200086A7 - Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes - Google Patents
Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentesInfo
- Publication number
- CU20200086A7 CU20200086A7 CU2020000086A CU20200086A CU20200086A7 CU 20200086 A7 CU20200086 A7 CU 20200086A7 CU 2020000086 A CU2020000086 A CU 2020000086A CU 20200086 A CU20200086 A CU 20200086A CU 20200086 A7 CU20200086 A7 CU 20200086A7
- Authority
- CU
- Cuba
- Prior art keywords
- drug
- activity against
- antimicrobial activity
- resistant pathogens
- against multi
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<p>La presente invención describe compuestos peptídicos sintéticos que combaten microorganismos patógenos de naturaleza bacteriana, y que presentan como microorganismos multirresistentes a antibióticos convencionales. Además, describe terapias de combinación que contienen dichos péptidos. Se describen composiciones farmacéuticas que comprenden a los compuestos peptídicos y sus combinaciones.</p>
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2020000086A CU20200086A7 (es) | 2020-11-19 | 2020-11-19 | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
MX2023005925A MX2023005925A (es) | 2020-11-19 | 2021-11-18 | Entidades peptidicas con actividad antimicrobiana frente a patogenos multi-drogoresistentes. |
CN202180071094.XA CN116406282A (zh) | 2020-11-19 | 2021-11-18 | 具有针对多药耐药性病原体的抗微生物活性的肽实体 |
JP2023523524A JP2024508205A (ja) | 2020-11-19 | 2021-11-18 | 多剤耐性病原体に対する抗菌活性を有するペプチド実体 |
EP21865361.6A EP4249500A2 (en) | 2020-11-19 | 2021-11-18 | Peptide entities with antimicrobial activity against multi-drug resistant pathogens |
CA3199519A CA3199519A1 (en) | 2020-11-19 | 2021-11-18 | Peptide entities with antimicrobial activity against multi-drug resistant pathogens |
PCT/CU2021/050011 WO2022105948A2 (es) | 2020-11-19 | 2021-11-18 | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
US18/037,534 US20240239849A1 (en) | 2020-11-19 | 2021-11-18 | Peptide entities with antimicrobial activity against multi-drug resistant pathogens |
CONC2023/0007878A CO2023007878A2 (es) | 2020-11-19 | 2023-06-15 | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2020000086A CU20200086A7 (es) | 2020-11-19 | 2020-11-19 | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20200086A7 true CU20200086A7 (es) | 2022-06-06 |
Family
ID=80684162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU2020000086A CU20200086A7 (es) | 2020-11-19 | 2020-11-19 | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
Country Status (9)
Country | Link |
---|---|
US (1) | US20240239849A1 (es) |
EP (1) | EP4249500A2 (es) |
JP (1) | JP2024508205A (es) |
CN (1) | CN116406282A (es) |
CA (1) | CA3199519A1 (es) |
CO (1) | CO2023007878A2 (es) |
CU (1) | CU20200086A7 (es) |
MX (1) | MX2023005925A (es) |
WO (1) | WO2022105948A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117756904B (zh) * | 2023-12-22 | 2024-05-24 | 潍坊医学院 | 一种订书肽及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6940796A (en) * | 1995-08-23 | 1997-03-19 | University Of British Columbia, The | Antimicrobial cationic peptides and methods of screening for the same |
CU24073B1 (es) | 2011-12-27 | 2015-01-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | COMPOSICIÓN A PARTIR DE EXTRACTO DE HEMOCITOS DE LANGOSTA PARA LA DETECCIÓN DE LIPOPOLISACÁRIDOS, PEPTIDOGLICANOS Y 1,3-ß-D-GLUCANOS |
JP7253257B2 (ja) * | 2017-05-11 | 2023-04-06 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー- ユーシーエルエー メディカル センター | アルファコアヘリックスを有する抗微生物ペプチド |
-
2020
- 2020-11-19 CU CU2020000086A patent/CU20200086A7/es unknown
-
2021
- 2021-11-18 MX MX2023005925A patent/MX2023005925A/es unknown
- 2021-11-18 WO PCT/CU2021/050011 patent/WO2022105948A2/es active Application Filing
- 2021-11-18 CN CN202180071094.XA patent/CN116406282A/zh active Pending
- 2021-11-18 EP EP21865361.6A patent/EP4249500A2/en active Pending
- 2021-11-18 US US18/037,534 patent/US20240239849A1/en active Pending
- 2021-11-18 CA CA3199519A patent/CA3199519A1/en active Pending
- 2021-11-18 JP JP2023523524A patent/JP2024508205A/ja active Pending
-
2023
- 2023-06-15 CO CONC2023/0007878A patent/CO2023007878A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2023007878A2 (es) | 2023-07-21 |
US20240239849A1 (en) | 2024-07-18 |
CN116406282A (zh) | 2023-07-07 |
MX2023005925A (es) | 2023-05-29 |
JP2024508205A (ja) | 2024-02-26 |
EP4249500A2 (en) | 2023-09-27 |
WO2022105948A2 (es) | 2022-05-27 |
WO2022105948A3 (es) | 2022-10-20 |
CA3199519A1 (en) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018010459A2 (es) | Composiciones que comprenden cepas bacterianas | |
CL2018003265A1 (es) | Modulares del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos. | |
CO2018011701A2 (es) | Formulaciones de antibióticos glicopeptídicos estabilizados | |
CL2017002482A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
BR112019024264A2 (pt) | Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer | |
BR112018005114A2 (pt) | um novo polipeptídeo de endolisina | |
BR112015029367A8 (pt) | combinação compreendendo oxazolidinonaquinolonas, seu uso, composição farmacêutica, e kit de partes | |
CL2019003078A1 (es) | Nuevos derivados de pirazol bicíclicos. | |
CU20200086A7 (es) | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes | |
EP3574900A8 (en) | New applications of rifamycin-nitroimidazole coupling molecules | |
AR119025A1 (es) | Composición que comprende un bacillus formador de biopelícula | |
EP3795169A4 (en) | RECOMBINANT PROTEIN DERIVED FROM A BACTERIOPHAGE WITH ANTIMICROBIAL ACTIVITY AGAINST PATHOGENIC GRAM-NEGATIVE BACTERIA | |
WO2020102901A8 (en) | Synthetic antibacterial compounds and uses thereof | |
CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
BR112022000041A2 (pt) | Inibidores de detecção de quorum e / ou metabólitos pósbióticos e métodos relacionados | |
CO2021000147A2 (es) | Composición agrícola | |
MX2021015961A (es) | Moleculas novedosas. | |
MX2021014310A (es) | Formulaciones de terlipressina. | |
CL2021003317A1 (es) | Medicamento y uso del mismo para tratar infecciones bacterianas que involucran una biopelícula. | |
BR112012015154A2 (pt) | "combinação sinergética de protioconazol e metominostrobin." | |
BR112022012368A2 (pt) | Composto, e, composição farmacêutica para o tratamento de doenças associadas a diacilglicerol aciltransferase 2 | |
BR112013008037A2 (pt) | compostos multivalentes como tratamento antibiótico | |
BR112021023169A2 (pt) | Métodos e composições para fermentação bacteriana anaeróbica | |
EP3821903A4 (en) | USING THE RECOMBINANT ANTIBACTERIAL ENZYME LYSSAP26 TO EFFECTIVELY KILL PATHOGENIC BACTERIA | |
BR112019003861A2 (pt) | compostos contendo monoterpenoides / fenilpropanóides e métodos de sua fabricação e uso como tratamentos de sementes |